US China Trade War Paused - Clear Market Positive
In a joint statement, the United States and China have agreed to a 90-day reduction of tariffs, with the U.S. tariff on Chinese goods at 30% (10% plus the 20% fentanyl-related tariffs) and the Chinese tariff on U.S. goods at 10%. In the announcement, China has agreed to “remove the nontariff countermeasures taken against the United States since April 2, 2025,” and talks addressed China’s restrictions on the export of certain rare earth minerals. The U.S. and China have agreed to a series of follow-up negotiations over the next 90 days. This is a clear market positive and the 30% tariff is lower than expected (given reports that it could be 50%, 80% etc.). In the next 90 days, we will be watching negotiations closely and expect to see volatility. Additional relief on penalties on Chinese-flagged vessels, progress on the 20% fentanyl-related tariffs, and the impact on the status of the de minimis exemption remain important provisions to track.
What’s included? A 90-day pause of tariffs implemented through three executive orders by President Trump and China’s removal of tariffs and non-tariff countermeasures were announced as part of a joint statement of the U.S. and Chinese government on Monday, May 12, 2025. This announcement will bring U.S. tariffs on Chinese goods from 145% to 30% and Chinese tariffs on U.S. goods from 125% to 10%. This announcement follows meetings over the weekend between U.S. Treasury Secretary Scott Bessent, U.S. Trade Representative Jamieson Greer, and Chinese Vice Premier He Lifeng.
In the announcement, China will suspend its non-tariff countermeasures implemented since April 2, which we understand to include restrictions on certain critical minerals. We view this as one of the most important aspects of the announcement, as U.S. industrial production would be significantly impaired within six to nine months without this change. Reports have generally been conflicting, and it is unclear which pre-April 2/broader export controls that they will keep in place and/or strengthen. However, this remains a critical issue to monitor and something that will highly incentivize the U.S. to cut a deal.
What’s not included? No changes to penalties of up to $1.5 million for a Chinese made ship entering a U.S. port. The joint statement discusses reductions to the “ad valorem rate of duty” but does not make mention of the “per postal item containing goods duty,” which has increased the cost of shipping on goods that previously relied upon the de minimis exemption. In our conversation with our contacts, they have highlighted the penalty on Chinese-made ships as having a greater impact than the tariffs on Chinese goods, creating incentives for shipments to avoid U.S ports and creating a hub and spoke model for Canadian, Mexican, and Caribbean ports. These penalties will increase costs and delay shipments into the U.S. Sectoral tariffs are not included in this announcement.
Impact for sectoral tariffs. We continue to expect tariff announcements for semiconductors and pharmaceuticals in coming weeks, which are likely to be set at a rate of at least 25%. Other trade investigations, including a potential export ban on copper and on critical minerals, remain ongoing. In press remarks this morning, Bessent highlighted that while the U.S. is not seeking to fully decouple from China, “what we do want is a decoupling for strategic necessities.” In his comments, he specifically highlighted steel, medicines, and pharmaceuticals — all of which have been through/are currently in the process of a Section 232 trade investigation.
However, with China addressing its export ban on rare earth minerals as a part of this pause, there is an argument that this lowers the chance of a ban on copper scrap exports to China.
Next steps. Per the announcement, the U.S. and Chinese delegations will continue to meet over the next 90 days. Meetings will be held in the U.S., China, and potentially other countries. We expect Treasury Secretary Bessent and USTR Greer to lead the talks for the United States, which we view as a net positive. Any trade deal will be subject to President Trump’s approval, which we expect will come with periods of volatility. The reduction of an effective tariff to 30%, with the ability to go lower if progress is made on the 20% fentanyl-related tariffs, is better than expected and well below the 80% President Trump teased on social media last week. The 145% from the U.S. and 125% from China was a functional embargo.
Statement (bolded for key portions and links to relevant executive orders).
“The Parties commit to take the following actions by May 14, 2025:
The United States will (i) modify the application of the additional ad valorem rate of duty on articles of China (including articles of the Hong Kong Special Administrative Region and the Macau Special Administrative Region) set forth in Executive Order 14257 of April 2, 2025, by suspending 24 percentage points of that rate for an initial period of 90 days, while retaining the remaining ad valorem rate of 10 percent on those articles pursuant to the terms of said Order; and (ii) removing the modified additional ad valorem rates of duty on those articles imposed by Executive Order 14259 of April 8, 2025 and Executive Order 14266 of April 9, 2025.
China will (i) modify accordingly the application of the additional ad valorem rate of duty on articles of the United States set forth in Announcement of the Customs Tariff Commission of the State Council No. 4 of 2025, by suspending 24 percentage points of that rate for an initial period of 90 days, while retaining the remaining additional ad valorem rate of 10 percent on those articles, and removing the modified additional ad valorem rates of duty on those articles imposed by Announcement of the Customs Tariff Commission of the State Council No. 5 of 2025 and Announcement of the Customs Tariff Commission of the State Council No. 6 of 2025; and (ii) adopt all necessary administrative measures to suspend or remove the non-tariff countermeasures taken against the United States since April 2, 2025.
After taking the aforementioned actions, the Parties will establish a mechanism to continue discussions about economic and trade relations. The representative from the Chinese side for these discussions will be He Lifeng, Vice Premier of the State Council, and the representatives from the U.S. side will be Scott Bessent, Secretary of the Treasury, and Jamieson Greer, United States Trade Representative. These discussions may be conducted alternately in China and the United States, or a third country upon agreement of the Parties. As required, the two sides may conduct working-level consultations on relevant economic and trade issues.”
Securities offered through Raymond James Financial Services, Inc., member FINRA/SIPC. Reynolds Wealth Management is not a registered broker/dealer and is independent of Raymond James Financial Services. Investment advisory services offered through Raymond James Financial Services Advisors, Inc. This information is intended to be educational and is not tailored to the investment needs of any specific investor. Every investor's situation is unique, and you should consider your investment goals, risk tolerance and time horizon before making any investment. Prior to making an investment decision, please consult with your financial advisor about your individual situation. Raymond James and its advisors do not offer tax or legal advice. You should discuss any tax or legal matters with the appropriate professional.
RJA is registered with the Financial Industry Regulatory Authority (FINRA) as a member firm. RJA is responsible for the preparation and distribution of reports created in the United States. RJA is located at The Raymond James Financial Center, 880 Carillon Parkway, St. Petersburg, Florida 33716 (Raymond James Financial (RJF) Corporate Headquarters), 727.567.1000. Raymond James Financial Services, Inc. (RJFS) is registered with FINRA as a Member Firm. RJFS is located at the RJF Corporate Headquarters.
This report is not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident of or located in a locality, state, province, country, or other jurisdiction where such distribution, publication, availability, or use would be strictly prohibited or contrary to law or regulation. The securities discussed in this report may not be eligible for sale in some jurisdictions. This research is not an offer to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer or solicitation would be illegal. It is not investment advice and does not constitute a personal recommendation, nor does it take into account the particular investment objectives, financial situations, or needs of individual clients. Information in this report should not be construed as advice designed to meet the individual objectives of any particular investor. Investors should consider this report as only a single factor in making their investment decision. Some investments discussed in this report may have a high level of volatility. High volatility investments may experience sudden and large falls in their value causing losses when that investment is realized. Those losses may equal your original investment. Consultation with your Raymond James representative is recommended. Past performance is not a guide to future performance, future returns are not guaranteed, and a loss of original capital may occur. Nothing in this report constitutes investment, legal, accounting or tax advice or is a representation that any investment or strategy is suitable or appropriate to your individual circumstances or otherwise constitutes a personal recommendation to you.
The information provided is as of the date above and is subject to change and may or may not be updated. This report should not be deemed a recommendation to buy or sell any security. Certain information has been obtained from third-party sources Raymond James considers reliable, but Raymond James does not guarantee that such information is accurate or complete. Persons within Raymond James may have information that is not available to the contributors of the information contained in this report. Raymond James, including affiliates and employees, may execute transactions in the securities listed in this report that may not be consistent with the ratings appearing in this report. With respect to materials prepared by Raymond James, all expressions of opinion reflect the judgment of the Research Departments of Raymond James, or its affiliates, as of the date above and are subject to change. Raymond James may perform investment banking or other services for, or solicit investment banking business from, any company mentioned in this report.
Raymond James reports are disseminated and available to Raymond James clients simultaneously via electronic publication to Raymond James' internal proprietary websites (RJA: RJ Client Access & raymondjames.com; RJL: RJL ECM Client Access, RJL Retail Client Access & raymondjames.ca). Not all reports are directly distributed to clients or third-party aggregators. Certain maintenance reports may only be disseminated on Raymond James' internal proprietary websites; however, such reports will not contain changes to target price, valuation, or investment or suitability rating. Individual Raymond James associates may also opt to circulate published reports to one or more clients electronically. This electronic communication distribution is discretionary and is undertaken only after the report has been publicly disseminated via publication to RJ's internal proprietary websites. The level and types of communications provided by Raymond James associates to clients may vary depending on various factors including, but not limited to, the client's individual preference as to the frequency and manner of receiving communications. For reports, models, or other data available on a particular security, please contact your Raymond James representative or financial advisor or visit for RJA: RJ Client Access & raymondjames.com; RJL: RJL ECM Client Access, RJL Retail Client Access & raymondjames.ca.
Raymond James’ policy is to update reports as it deems appropriate, based on developments with the subject company, the sector or the market that may have a material impact on the research views or opinions stated in a report. Raymond James' policy is only to publish reports that are impartial, independent, clear, and fair and not misleading. Any information relating to the tax status of the securities discussed in this report is not intended to provide tax advice or to be used by anyone to provide tax advice. Investors are urged to seek tax advice based on their particular circumstances from an independent tax professional.
Links to third-party websites are being provided for information purposes only. Raymond James is not affiliated with and does not endorse, authorize, or sponsor any of the listed websites or their respective sponsors. Raymond James is not responsible for the content of any third-party website or the collection or use of information regarding any website's users and/or members. Raymond James has not reviewed any such thirdparty websites and takes no responsibility for the content contained therein. Such address or hyperlink (including addresses or hyperlinks to Raymond James’ own website material) is provided solely for your convenience and information, and the content of any such website does not in any way form part of this report. Accessing such website or following such link through this report or Raymond James’ website shall be at your own risk. Additional information is available on request.
All right, title, and interest in any Raymond James reports is the exclusive property of Raymond James Financial, Inc. and its affiliates, except as otherwise expressly stated. Raymond James® is the registered trademark of Raymond James Financial, Inc. All trademarks, service marks, slogans, logos, trade dress and other identifiers, third-party data and/or market data (“intellectual property”) displayed in the Raymond James reports are the property of Raymond James, or of other parties. The names of other companies and third-party products or services or other intellectual property mentioned in the Raymond James reports may be the copyright, trademarks, or service marks of their respective owners. U.S. and foreign copyright, trademark, common law rights and statutes protect this intellectual property. You are prohibited from using any intellectual property for any purpose including, but not limited to, use on other materials, in presentations, as domain names, or as metatags, without the express written permission of Raymond James or such other party that may own the marks.
